CPH Group AG (SWX:CPHN)

Market Cap	357.30M -11.6%
Revenue (ttm)	334.23M +3.7%
Net Income	20.49M -32.7%
EPS	3.42 -32.6%
Shares Out	6.00M
PE Ratio	17.42
Forward PE	13.26
Dividend	2.00 (3.36%)
Ex-Dividend Date	Mar 19, 2026

Volume	327
Open	59.60
Previous Close	59.80
Day's Range	59.40 - 59.60
52-Week Range	54.20 - 71.40
Beta	0.21
Analysts	Buy
Price Target	78.50 (+31.71%)
Est. Earnings	Feb 19, 2027

About CPH Group AG

CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. It operates through two segments: Zeochem and Perlen Packaging. The Zeochem segment produces molecular sieves for industrial and medical applications, chromatography gels for the pharmaceutical industry, and deuterated products used in analytics, pharmaceuticals, and OLED displays. This segment also operates production facilities in Switzerland,...

• Industry: Paper & Paper Products
• Sector: Materials
• Founded: 1818
• Employees: 1,249
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: CPHN

Financial Performance

In 2025, CPH Group AG's revenue was 334.06 million, a decrease of -25.41% compared to the previous year's 447.86 million. Earnings were 23.36 million, an increase of 402.58%.

Analyst Summary

According to 3 analysts, the average rating for CPHN stock is "Buy." The 12-month stock price target is CHF 78.50, which is an increase of 31.71% from the latest price.

Price Target

CHF 78.50

(31.71% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error